Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Alexander Nguyen

Emergency Medicine Lapeer, MI Medical Doctor

NPI 1174151740 CMS profile 7675754

1375 N Main St, Lapeer, MI 48446

Open in the dashboard

General payments

$7,141

57 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Nguyen of Lapeer, MI is reported in the CMS Open Payments database as having received $7,141 across 57 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,683 18
2024 General $2,203 19
2023 General $2,254 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Nguyen
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Alexander Nguyen were reported at $2,683. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Alexander Nguyen Emergency Medicine median Middle half National median
2019 $0 $51 $18–$128 $163
2020 $0 $29 $16–$99 $114
2021 $0 $40 $18–$124 $132
2022 $0 $49 $20–$134 $149
2023 $2,254 $51 $22–$142 $160
2024 $2,203 $52 $22–$150 $164
2025 $2,683 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Medtronic, Inc. $3,258 33 payments
  2. Boston Scientific Corporation $3,114 16 payments
  3. Painteq LLC $257 1 payment
  4. Globus Medical, Inc. $242 2 payments
  5. Abbott Laboratories $195 3 payments
  6. Ethicon US, LLC $44 1 payment
  7. Nevro Corp. $32 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $3,670 42 payments
  2. Travel and Lodging $3,471 15 payments
Products named General payments · program years 2023–2025
  1. General - Therapies $1,830 5 payments
  2. VANTA ADAPTIVESTIM $1,732 14 payments
  3. INTELLIS ADAPTIVESTIM $1,373 15 payments
  4. PAINTEQ $257 1 payment
  5. Senza $242 2 payments
  6. OBSIDIO $172 1 payment
  7. PROCLAIM $123 2 payments
  8. KYPHON EXPRESS II KYPHOPAK TRAY $100 2 payments
  9. General - Pain Management $84 2 payments
  10. ETERNA $71 1 payment
  11. Other $181 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

442

Median for Emergency Medicine: 88

Drug cost

$10,695

Median for Emergency Medicine: $590

Branded share of claims

34.2%

Median for Emergency Medicine: 33.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Buprenorphine Generic 18 $4,515
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 110 $1,445
Naloxone Hcl Generic 15 $908
Gabapentin Generic 75 $898
Lidocaine Generic 11 $843
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 26 $435
Pregabalin Generic 43 $391
Tizanidine Hcl Generic 37 $351
Acetaminophen-Codeine Acetaminophen With Codeine Brand 15 $285
Duloxetine Hcl Generic 17 $189

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$11,187

Medicare's payments for the services billed

Medicare patients

67

Average age 70

Services billed

166

41 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Depression 39%
Diabetes 31%
COPD 27%
Ischemic heart disease 25%
Atrial fibrillation 16%
Cancer 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

57 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record